Investigation of Interleukin-6 (IL-6) as Prognostic Marker
27th ECVIM-CA Congress, 2017
S. Neumann; J. Schuettler; S. Fischer
University of Goettingen, Goettingen, Germany

The assessment of the disease course is essential to make a prognosis and important part of daily veterinary and human clinical practice. Different parameters are used with different success. IL-6, a pro-inflammatory cytokine, may have some prognostic value which was showed by some human studies. The mechanism why IL-6 is elevated in cases of bad prognosis is still unknown. We investigated the prognostic value of IL-6 in dogs, cats, and cattle.

Twenty-nine dogs, patients of a critical care unit were included in this study. The dogs suffered from different severe life-threatening diseases like pancreatitis or sepsis. IL-6 was measured at first consultation. The patients were treated with disease specific treatment and the clinical course was observed. Finally, clinical outcome and IL-6 concentration were compared.

Eight cats suffering from chronic kidney disease in an advanced stage were treated and the clinical outcome was compared with the IL-6 serum concentration at the time of hospitalization.

In cattle 20 calves suffering from diarrhea were investigated. Here the recovering period was compared with the incoming IL-6 serum concentration. None of these calves died.

IL-6 was measured with species specific ELISA according to manufactures instructions.

The dogs could be differentiated into survivors (20) and non-survivors (9). The IL-6 serum concentration in the group of non-surviving dogs was significantly elevated compared to surviving dogs (p<0.001).

Cats with chronic kidney disease which do not survive the treatment showed significantly higher IL-6 serum concentration compared to surviving cats (p<0.001).

At the beginning of diarrhea, the IL-6 concentration was significantly higher in calves with an extended recovering period compared with those that recovered 7 to 10 days after the onset of diarrhea (p<0.05).

To get information about the outcome of a life-threatening disease can be important to give the owners some advice and to make treatment decisions. IL-6 which is mainly known as pro-inflammatory cytokine and which is elevated in sepsis and inflammatory response syndrome, was successfully assessed as prognostic marker in humans. In our studies, we have proved that IL-6 is also useful in dogs and cats suffering from life threatening inflammatory and non-inflammatory diseases and can give information about the disease outcome. In claves, we could show that the recovering period can also be predicted by IL-6. So, in conclusion, IL-6 seems to be a valuable prognostic marker in different species with different diseases.

Disclosures

No disclosures to report.

  

Speaker Information
(click the speaker's name to view other papers and abstracts submitted by this speaker)

S. Neumann
University of Goettingen
Goettingen, Germany


MAIN : ESVCP : Interleukin-6 as Prognostic Marker
Powered By VIN
SAID=27